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Abstract 
Objective: Although azelaic acid is effective for treatment of acne 
and rosacea, the biological activity of azelaic acid and the effect of 
its combination therapy with minoxidil were not elucidated with 
regard to hair growth. 
Materials and Methods: In this study, mouse vibrissae follicles 
were dissected on day 10 after depilation. Then, the bulb and bulge 
cells of the hair follicle were treated with minoxidil and azelaic acid 
for 10 days to evaluate Sonic hedgehog (Shh) protein expression. 
Moreover, bulge and bulb cells of the hair follicles were cultivated 
and the expression of Gli1, Gli2, and Axin2 mRNA levels was 
evaluated using real-time polymerase chain reaction (PCR) 
analysis. We further investigated the protective effects of azelaic 
acid against ultraviolet B (UVB) irradiation in cultured bulb and 
bulge cells by determining catalase activity. An irradiation dose of 
20 mJ/cm2 UVB for 4 sec was chosen. 
Results: The results showed that catalase activity significantly 
(p<0.05) increased in the bulge cells after exposure to 2.5 mM and 
25 mM azelaic acid. Meanwhile, treatment of the bulb cells with 
azelaic acid (2.5 and 25 mM) did not cause significant changes in 
catalase activity. We also found that azelaic acid (25 mM) alone 
upregulated Gli1 and Gli2 expression in the bulge cells and 100 µ 
minoxidil caused Gli1 and Axin2 overexpression in the bulb region 
of the hair follicle. Moreover, minoxidil (100 µM) alone and in 
combination with azelaic acid (25 mM) led to Shh protein 
overexpression in the hair follicles in vitro and in organ culture.  
Conclusion: Our results indicated a potential role for azelaic acid 
in the protection of bulge cells from UVB damage and its 
combination with minoxidil may activate hair growth through 
overexpression of Shh protein.
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Introduction 
Hair follicle undergoes cyclic 
morphogenetic changes of anagen, catagen, 
and telogen, throughout life (Krause and 
Foitzik, 2006). These cyclic changes 
involve interactions between epithelial and 
dermal cells of the hair follicle (Sennett and 
Rendl, 2012). There are multipotent stem 
cells with self-renewal capability in the 
bulge region of the hair follicles 
(Najafzadeh et al., 2015). The bulge stem 
cells can migrate to the lower part of the 
hair follicle within the outer root sheath and 
reconstitute the matrix cells at the end of 
telogen (Myung and Ito, 2012). The bulge 
stem cells are slow cycling cells (Cotsarelis 
et al., 1990) and regenerate lower half of the 
hair follicle during the anagen phase 
(Morris et al., 2004).  
The hair follicle stem cells (HFSCs) 
residing in the bulge region are maintained 
by activation of Wnt and sonic hedgehog 
(Shh) signaling pathways. Shh directs 
patterning and cellular differentiation 
during embryonic development of the skin 
and hair follicle. Moreover, Shh is involved 
in controlling anagen stage of hair follicle 
during postnatal life (Chiang et al., 1999). 
In vertebrates, three Gli proteins, Gli1, 
Gli2, and Gli3 are involved in Shh 
signaling. Gli1 is a transcriptional activator, 
whereas Gli2 and Gli3 act as either 
activator or repressor. Gli2 protein plays a 
critical role during the development of the 
hair follicles. It induces cell proliferation in 
the hair follicles by activating cyclin D1 and 
cyclin D2 (Mill et al., 2003). The dermal 
papilla and outer root sheath cells of the hair 
follicle express Gli1 and Gli2 during 
anagen (Paladini et al., 2005). The Wnt 
target gene Axin2 expression persists in the 
bulge stem cells during the initiation of hair 
growth phase (Lim et al., 2016). 
Androgenetic alopecia (AGA) affects 
about 30-50% of men and 13-37% of 
women by the age of 50 years old 
(Hamilton, 1951; Venning and Dawber, 
1988). AGA is related to genetic and 
androgens including testosterone and 
dihydrotestosterone (DHT). DHT is a more 
potent androgen that can activate genes 
responsible for scalp hair follicle 
miniaturization (Inui and Itami, 2011). In 
AGA, hair growth is ceased while telogen 
duration prolongs and leads to the 
conversion of terminal hairs into vellus 
hairs (Otberg et al., 2007). Based on such 
knowledge, minoxidil induces the initiation 
of the anagen phase and prolongs its 
duration (Messenger and Rundegren, 
2004). Minoxidil stimulates peripheral 
vasodilation around the hair follicle and 
promotes dermal papilla cells survival and 
proliferation (Han et al., 2004). It can also 
induce prostaglandin-endoperoxide 
synthase-1 and upregulate vascular 
endothelial growth factor (Lachgar et al., 
1998). 
In recent years, due to negative 
psychosocial impact of alopecia, patients 
turn to alternative medicine that has not yet 
been clarified for their effectiveness. 
Recently, the beneficial effects of herbal 
extracts such as pumpkin seed oil 
(Hajhashemi et al., 2019), Citrullus 
colocynthis, and Rosmarinus officinalis 
were evaluated (Hosking et al., 2019). 
Azelaic acid was previously used in the 
treatment of rosacea, acne, and melasma 
(Frampton and Wagstaff, 2004). In human 
keratinocytes, azelaic acid induces PPARγ 
transcriptional activity (Mastrofrancesco et 
al., 2010) and suppresses IL-1β, IL-6, and 
TNF mRNA expression. In earlier studies, 
it was shown that azelaic acid reduces 
inflammation and may act as a potent 5α-
reductase inhibitor (Stamatiadis et al., 
1988) which may reduce hair loss. Azelaic 
acid has not been extensively studied as a 
treatment for hair loss. In many products, 
azelaic acid has been combined with 
minoxidil to treat AGA (Hordinsky and 
Donati, 2014). Some dermatologists 
prescribe commercial solutions 
supplemented with azelaic acid for AGA 
(Sasmaz and Arican, 2005). A great part of 
azelaic acid effect against hair loss may be 
related to its anti-inflammatory properties; 
however, there is little evidence to prove 
the efficacy of azelaic acid on hair growth. 
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Targeting and inhibiting DHT and 
inflammation would be a rational approach 
for developing novel therapeutics for 
treatment of hair loss. In this study, we 
hypothesized that induction of the 
overexpression of Gli1, Gli2, and Axin2 in 
hair follicle by azelaic acid may initiate hair 
regrowth. Overall, there is a need for 
additional studies to evaluate possible 
mechanism underlying azelaic acid effect 
by evaluating the expression of Shh protein 
and the anagen promoting genes such as 
Gli1, Gli2, and Axin2 in the hair follicles. 
 
 
Materials and Methods 
Drugs and reagent 
Minoxidil and azelaic acid were 
purchased from Sigma-Aldrich (St Louis, 
MO, U.S.A). Minoxidil was dissolved in 
HCl and azelaic acid was dissolved in 
culture medium. 
 
Animals 
Male BALB/c mice (6-8 weeks old) 
were obtained from Razi Vaccine and 
Serum Research Institute (Karaj, Iran). The 
animals were kept under a 12:12 hr 
light/dark cycles and they had free access to 
food and water. The experimental 
procedures were performed in accordance 
with the guidelines of the Animal Care and 
Use Committee of Ardabil University of 
Medical sciences 
(IR.ARUMS.REC.1394.50). 
 
Isolation of bulb and bulge regions 
All mice upper lip hairs were depilated 
to synchronize the hair follicles in anagen. 
Ten days later, the whisker pads were 
collected. Briefly, after anesthesia 
induction using dimethyl ether, anagen 
stage-follicles were dissected from the 
whisker pads under a stereomicroscope 
(Olympus, Tokyo, Japan). The vibrissa hair 
follicles lifted out and treated with 
minoxidil (100 μM), azelaic acid (25 mM) 
alone and azelaic (25 mM)/minoxidil (100 
µM). Then, the bulge regions were isolated 
from the hair follicles. Bulb region was also 
isolated by cutting a piece of around 2–2.5 
mm in length from the bottom of the hair 
follicle (Dastan et al., 2016). 
 
UVB irradiation 
Bulb and bulge cells of the hair follicle 
were cultured in Dulbecco’s Modified 
Eagle’s medium: nutrient mixture Ham’s 
F12 medium (DMEM: F12). Prior to the 
irradiation, the medium was replaced by 
phosphate buffered saline (PBS). An 
irradiation dose of 20 mJ/cm2 UVB was 
chosen based on previous results 
(Mastrofrancesco et al., 2010). The average 
irradiation time was 4 sec. After irradiation, 
the cells were immediately returned to the 
culture medium with or without addition of 
azelaic acid (2.5 and 25 mM for 7 days). 
Sham cells were irradiated, but control cells 
were incubated in DMEM/ F12 medium 
without UVB exposure. 
 
Determination of catalase activity 
The bulb and bulge regions were isolated 
and the cells were cultivated in DMEM: 
F12 supplemented with 100 U/ml penicillin 
and 100 µg/ml streptomycin. The groups 
were: (i) control (untreated bulb and bulge 
cells); (ii) Sham (untreated bulb and bulge 
cells+UV irradiation); (iii) UV+2.5 mM 
azelaic acid; (iv) UV+25 mM azelaic acid; 
(v) 2.5 mM azelaic acid+UV; (vi) 25 mM 
azelaic acid+UV.  
Catalase activity was measured 
according to Aebi method (Aebi, 1984). 
Briefly, the bulb and bulge cells were 
washed and suspended in 0.1 M Tris-HCl 
(pH 7.5) for 20 min on ice. Then, the cells 
were sonicated for two 30-sec bursts. After 
10 min of centrifugation at 14000 
relative centrifugal force (RCF), aliquots of 
the obtained supernatant were subjected to 
three freeze-thaw cycles at -80°C. Next, 
50 μl supernatant was diluted 500 times 
with PBS and 2 μl of that was added to 1 ml 
hydrogen peroxide (30 mM). The 
absorption was monitored by a 
spectrophotometer (Shimadzu, UV-1800) 
at λ=240 nm every 15 sec for 2 min. Assays 
were performed in triplicate. 
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Immunoassay 
Immunohistochemistry was performed 
as described previously (Najafzadeh et al., 
2013). Briefly, ten-micron sections were 
prepared, mounted on slides and 
deparaffinized. After rehydration, the 
sections were incubated in blocking 
solution (PBS with 5% normal goat serum, 
0.3% Triton X-100 and 1% bovine serum 
albumin) at room temperature for 60 min. 
The cells were incubated with primary 
antibody against Shh (sc-9024; Santa Cruz, 
1:100). Then, the cells were stained with the 
secondary antibody (donkey anti-rabbit 
Alexa Fluor 488 (Invitrogen, A21206, 
1:200) (Najafzadeh et al., 2015). For 
immunocytochemistry, after fixation using 
paraformaldehyde, the cells were blocked 
and stained with primary antibody (anti-
Shh (1:100)) and secondary antibody 
(Alexa Fluor 488 (1:200)). The cells were 
visualized by a fluorescence microscope 
(IX71, OLYMPUS). 
  
Quantitative real-time PCR (qRT-PCR) 
analysis 
The anagen hair follicles were treated 
with minoxidil, azelaic acid and the 
combination of them for 10 days. In all 
experiments, the tissue culture medium 
containing minoxidil or azelaic acid, was 
changed every two days. Then, the 
follicular bulge and bulb regions were 
isolated for real-time PCR analysis. Total 
mRNAs was extracted from the hair 
follicles using TRIzol reagent (Invitrogen, 
Carlsbad, CA). The concentration of total 
mRNA was measured using a NanoDrop 
Spectrophotometer (Thermo Scientific, 
USA). cDNA was synthesized from total 
RNA using a cDNA Synthesis Kit 
(Fermentas, Thermo Fisher Scientific, 
USA). Reactions were performed in a final 
volume of 20 μl (master mix 10 μl, cDNA 
4 μl, primer 2 μl, and H2O 4 μl). The primer 
sequences and products lengths are shown 
in Table 1. Quantitative PCR was carried 
out using Power SYBR Green PCR Master 
Mix (EURx, Ltd, Gdañsk, Poland) and real-
time PCR System (Applied Biosystems 
7500, Foster City, CA, USA). The cycling 
initiated with denaturation at 95°C for 10 
min, followed by 50 cycles of denaturation 
at 95°C for 10 sec, annealing at 60°C for 20 
sec and extension at 72°C for 10 sec. Β2-
microglobulin (B2M) gene was applied as 
the housekeeping gene for normalization of 
the real-time data. The 2−ΔΔCt formula was 
used to calculate relative changes in gene 
expression (Dastan et al., 2016; 
Mohammadi Jobani et al., 2018). 
ΔΔCt = (ΔCt(sample) – ΔCt (control)) 
 
Statistical analysis 
Statistical analysis was done by one-way 
analysis of variance (ANOVA). p 
values<0.05 were regarded as statistically 
significant. Graphs were plotted using 
Sigma Plot software (version 12.0, Systat 
Software Inc., SanJose, CA). 
 
 
Table 1. Sequences of the primers used to identify different genes in real-time PCR assays. 
 
Name Forward Primer (5’-3’) Reverse Primer (5’-3’) Product length 
Gli1 ACTAGGGGCTACAGGAGGA ACCTGGACCCCTAGCTTCAT 149 bp 
Gli2 ACCATGCCTACCCAACTCAG CCTCAGCCTCAGTCTTGACC 145 bp 
Axin2 AACCTATGCCCGTTTCCTCT CTGGTCACCCAACAAGGAGT 128 bp 
B2M CTGCTACGTAACACAGTTCCACCC  CATGATGCTTGATCACATGTCTCG  241 bp 
Results 
Azelaic acid induced catalase activity in 
bulge cells  
To evaluate the short-term sensitivity of 
hair follicle to UVB exposure, we irradiated 
the bulge and bulb regions of the hair 
follicle with a single dose of UVB.  
When azelaic acid (2.5 mM) was added 
into culture medium before UVB 
irradiation or when added promptly after 
irradiation, it significantly increased 
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catalase activity in the bulge cells (Figure 
1A). The increase in the catalase activity 
was also promoted by 25 mM azelaic acid 
in the bulge cells before UVB irradiation 
(Figure 1B). Treatment of the bulb cells 
with azelaic acid (2.5 and 25 mM) did not 
cause significant changes in the catalase 
activity (Figures 1C and D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Induction of catalase activity after azelaic acid (2.5 and 25 mM) treatment in the bulge (A and B) and 
bulb cells (C and D). Azelaic acid was added 30 min before UVB (20 mJ/cm2) (A and C) or promptly after UVB 
radiation (B and D). *p<0.05 when compared to control and sham. 
 
Minoxidil (100 µM) and its combination 
with azelaic acid (25 mM) increased the 
expression of Shh protein 
To elucidate whether the treated hair 
follicles undergo anagen phase, we tested 
the expression of Shh protein using 
immunoassay. Our results showed that Shh 
protein expression was increased in 100 µM 
minoxidil-treated cells compared to the 
control cells (untreated) on day 10 post-
treatment. In addition, as shown in Figure 
2, azelaic acid (25 mM)/minoxidil (100 
µM) combination treatment significantly 
increased Shh expression in the bulge and 
bulb cells when compared to control and 
minoxidil (100 µM). Minoxidil (100 µM) 
and azelaic acid (25 mM)/minoxidil (100 
µM) treatments also induced Shh protein 
expression in the outer root sheath of the 
hair follicles, while other treated groups 
lacked expression or had low levels of Shh 
protein expression (Figure 3). 
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Figure 2. Effects of minoxidil, azelaic acid, and the combination treatments on Shh expression in the bulb (a-f) 
and bulge (g-l) cells of the hair follicle. Bulb and bulge cells were cultured in medium without drugs (control, a 
and g), or with azelaic acid (25 mM), minoxidil (25 and 100 μM), azelaic acid (25 mM)/minoxidil (25 µM), and 
azelaic acid (25 mM)/minoxidil (100 µM). Shh expression was apparently seen in both minoxidil (100 µM) treated 
bulb (c and m) and bulge (i and n) cells. Indeed, azelaic acid (25 mM) combination with minoxidil (100 µM) 
significantly induced more Shh expression in the bulb (f and m) and bulge cells (l and n) (∗p<0.05). Azelaic acid 
(25 mM), minoxidil (25 µM), and azelaic acid (25 mM)/ minoxidil (25 μM) had no effect on Shh expression. *p< 
0.05 when compared to the control. #p<0.05 when compared to minoxidil (100 µM). 
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Figure 3. Effects of azelaic acid, minoxidil and the combination treatments on Shh expression in the hair follicles. 
Azelaic acid (25 mM) (b), minoxidil (25 µM) (c), and azelaic acid (25 mM)/minoxidil (25 µM) (e) had no 
significant effect on Shh expression, but minoxidil (100 µM) (d and g) and azelaic acid (25 mM)/minoxidil (100 
µM) (f, h, and k) treatments resulted in a significant increase in Shh protein expression in the hair follicles 
(*p<0.05). The arrows show Shh immunostaining in the outer root sheath of the hair follicles. *p<0.05 when 
compared to the control. #p<0.05 when compared to minoxidil (100 µM). 
 
Effects of minoxidil, azelaic acid and the 
combination treatments on Gli1, Gli2, 
and Axin2 expression 
In our study, we explored the effect of 
azelaic acid (25 mM), minoxidil (100 µM) 
and azelaic acid (25 mM)/minoxidil (100 
µM) on Gli1, Gli2, and Axin2 mRNA 
expression in the bulb and bulge regions of 
the hair follicles. The fold changes of Gli1 
and Gli2 mRNA levels were 194.81 and 
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10.82 in the azelaic acid-treated bulge cells, 
respectively. In addition, 100 µM 
minoxidil-treated bulb cells showed a 
significant increase in Gli1 (6.026-fold 
change) and Axin2 (5.15-fold change) 
mRNA level (Table 2). In contrast, 
minoxidil plus azelaic acid did not elevate 
the level of the gene expression compared 
to minoxidil alone, in bulge and bulb cells 
of the hair follicles. 
 
Table 2. mRNA expression levels of Gli1, Gli2, and Axin2 in the bulb and bulge regions of the hair follicles were 
analyzed by real time-PCR. The relative mRNA expression of different genes is presented as fold changes.  
 
Gli1 and Gli2 mRNA levels are statistically significant in azelaic treated bulge cells. Gli1 and Axin2 upregulated 
in minoxidil treated bulb cells (*P< 0.05 compared to control). 
 
 
Discussion 
In our results, the effectiveness of 
azelaic acid alone in inducing hair growth, 
was shown with respect to up-regulation of 
Gli1 and Gli2 genes and an increase in 
catalase activity in the bulge cells. Indeed, 
its combination with minoxidil also 
elevated Shh protein expression in the hair 
follicles and combination therapy had a 
higher effect over minoxidil alone in terms 
of increased Shh expression level. Similar 
to our results, previous studies showed that 
Shh/Gli1/Gli2 activation may directly 
promote telogen to anagen transition in the 
hair follicle (St-Jacques et al., 1998) and 
azelaic acid may exert various PPARγ-
independent effects in the hair follicle. 
Moreover, direct upregulation of Gli2 
shown here and by other studies (Mill et al., 
2003; Oro and Higgins, 2003) as Gli2 is a 
transcriptional partner for β-catenin, that 
acts in synergy to induce anagen promotion 
and hair growth morphogenesis (Reddy et 
al., 2001). Previously, Pantazi et al. showed 
that Gli2 promotes the survival of the 
keratinocytes by inhibiting apoptosis and 
deregulating cell cycle proteins (Pantazi et 
al., 2015). 
Several signals were previously shown 
to participate in the hair follicle cyclic 
changes. β-catenin, Shh, noggin, and 
STAT3 are key factors that trigger the 
anagen phase (Botchkarev and Kishimoto, 
2003). Shh/Gli regulate hair follicle cyclic 
growth by inducing telogen to anagen 
transition (Choi, 2018). Importantly, Gli1 
protein is expressed in LGR5- expressing 
hair follicle stem cells (Brownell et al., 
2011). Similar to our results, some studies 
attempted to use azelaic acid to treat 
androgenetic alopecia and telogen 
effluvium. Comparison of azelaic acid and 
anthralin for treatment of patchy alopecia 
areata showed that azelaic acid and 
anthralin gave similar results to hair 
regrowth (Sasmaz and Arican, 2005). 
Consistent with our study, Pazoki-Toroudi 
et al showed that topical use of azelaic acid 
combination with 12.5% minoxidil was 
more effective for hair regrowth and 
produced a significant decrease in shedding 
(Pazoki-Toroudi H et al., 2012). In another 
study, Gugle et al. demonstrated that 
minoxidil alone and a combination of 
minoxidil, azelaic acid, and tretinoin were 
equally effective in treatment of 
androgenetic alopecia and the combination 
  Bulge 
region 
  Bulb region  
Gene azelaic (25 
mM) 
minoxidil 
(100 µM) 
azelaic (25 mM)/minoxidil 
(100 µM) 
azelaic (25 mM) minoxidil 
(100 µM) 
azelaic (25 mm)/ minoxidil 
(100 µM) 
Gli1 168.19±35.99* 0.08±0.03 0.66±0.10 0.42±0.08 5.19±1.31* 0.056±0.012 
Gli2 9.72±1.58* 1.13±0.59 0.159±0.05 0.0034±0.0016 0.117±0.045 0.041±0.027 
Axin2 0.86±0.23 
 
0.19±0.09 0.157±0.11 0.023±0.0077 5.37±0.32* 0.021±0.005 
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therapy had no added advantage over 
minoxidil alone (Gugle et al., 2015). 
Furthermore, we showed that exposure 
of azelaic acid to bulge cells protected them 
from UVB damage and caused a significant 
increase in the catalase activity in the bulge 
area. Hair loss, like acne, is strongly linked 
to inflammatory factors and DHT 
(Knussmann et al., 1992). In scarring 
alopecia, hair follicle stem cells (bulge 
cells) degenerate resulting in permanent 
hair loss (Harries and Paus, 2009). Some 
PPARγ ligands such as azelaic acid, have 
anti-inflammatory activity for the treatment 
of cicatricial (scarring) alopecia (Mirmirani 
and Karnik, 2009). It inhibits neutrophil-
mediated reactive oxygen species (ROS) 
production (Akamatsu et al., 1991) and 
modulates the inflammatory process. 
Finally, we found that Axin2 mRNA 
level was significantly up-regulated in the 
bulb cells after 100 µM minoxidil 
treatment. Axin2 and PPARγ participate in 
a negative feedback loop to degenerate and 
inhibit β-catenin (Lecarpentier and Vallée, 
2016; Stamos and Weis, 2013). The 
degeneration of β-catenin in the cytoplasm 
protects the activation of target genes such 
as cyclin D and c-myc (Tetsu and 
McCormick, 1999). Most signaling 
pathways contain negative feedback loops, 
which silence the signaling after the initial 
stimuli (Jho et al., 2002). 
Our previous work revealed that 
minoxidil promotes anagen phases through 
up-regulation of β-catenin and Shh (Dastan 
et al., 2016). Transient activation of the 
Wnt signaling pathway is needed for the 
initiation of anagen and activation of bulge 
stem cells in the hair follicles (Lien et al., 
2014). Probably, Axin2 gene inhibits Wnt 
signaling in the bulb cells in a negative 
feedback mechanism after anagen initiation 
(Lim et al., 2016). Similar to our study, 
Kwack et al. demonstrated that minoxidil 
induces accumulation of β-catenin and up-
regulates the expression of Axin2, Lef-1, 
and EP2 (Kwack et al., 2011). In addition to 
activation of Wnt signaling, Shh is required 
for anagen progression of the hair follicle 
(Wang et al., 2000) and it may influence the 
bulb cells of hair follicles to express Gli1 
and Axin2. 
Shh signaling regulates dermal papilla 
fibroblasts and matrix keratinocytes 
interaction during embryonic follicle 
morphogenesis and postnatal hair follicles 
cycling (Callahan and Oro, 2001). Shh is 
expressed in the keratinocytes of hair 
matrix and it acts as a mitogen to induce 
anagen (St-Jacques et al., 1998). 
In conclusion, we showed that azelaic 
acid is a regulator of Gli1 and Gli2 genes 
and it can protect bulge cells from UVB 
damage. Our results suggest that azelaic 
acid combination with minoxidil promotes 
hair growth via induction of Shh protein 
expression in the hair follicles. Altogether, 
this evidence provides valuable insights 
into the role of azelaic acid in the hair 
follicles growth.  
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